NCT05669339 AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT04679480 Anti-PD1-antibody and Pulsed HHI for Advanced BCC Status ACTIVE_NOT_RECRUITING Phase PHASE2